Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 11 - 20 of about 171   

Articles published

GSK 1,571.06 -3.94 (-0.25%)
price chart
A $7.8bn Reason To Buy GlaxoSmithKline plc Today
GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) confirmed this morning that the three-part asset swap deal agreed with Novartis last year has completed.
GlaxoSmithKline plc (ADR) (NYSE:GSK) CEO Andrew Witty's Pay Cut By 46%  InvestCorrectly
GSK completes transaction with Novartis  The Australian (blog)
Why GlaxoSmithKline plc Is One Of The Most Exciting Stocks In The FTSE 100
Shares in GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) have made a strong start to 2015, with improving investor sentiment helping them to make gains of 11%.
Why The Tipsters Like AstraZeneca plc Better Than GlaxoSmithKline plc
The pharmaceuticals industry is recovering pretty well from the �patent cliff� problems when a number of key drugs lost their protection in recent years, and though there's increasing competition from generic drugs, our two big FTSE 100 players are ...
GlaxoSmithKline plc (ADR), Merck & Co., Inc., Pfizer Inc., Sanofi SA (ADR ...
Home > GlaxoSmithKline plc (ADR), Merck & Co., Inc., Pfizer Inc., Sanofi SA (ADR): Are Big Pharma Stocks In Trouble?
GlaxoSmithKline plc And SkyePharma PLC: A Match Made In Heaven?
GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) is a great stock for any portfolio. Indeed, the company has all the best qualities you could ask for - a high dividend yield, attractive valuation healthy balance sheet, dominant market position and a reliable ...
My ISA Watch List: Whitbread plc, GlaxoSmithKline plc And Dignity Plc
It's been well reported how big pharmaceutical firms such as GlaxoSmithKline lost business and profit margins thanks to generic competitors moving in on previous big-selling drugs timed-out on patent exclusivity.
3 Shares For Your 2015 ISA: Barclays PLC, Aviva plc And GlaxoSmithKline plc
Have you used up your �15,000 ISA allowance for 2014-15? If not, you only have until 5 April before a new �15,240 allowance commences.
Is Hikma Pharmaceuticals Plc Now A Better Buy Than GlaxoSmithKline plc?
In fact, GlaxoSmithKline has struggled to an extent with this problem. Evidence of this can be seen in its disappointing performance during the same period, with its bottom line growing by around 8% per annum in the last five years.
GlaxoSmithKline plc's Overweight Rating Reiterated at Barclays (GSK)  Dakota Financial News
GlaxoSmithKline plc Stock Rating Reaffirmed by Shore Capital (GSK)
GlaxoSmithKline plc logo GlaxoSmithKline plc (NYSE:GSK)'s stock had its �buy� rating reiterated by investment analysts at Shore Capital in a note issued to investors on Friday.
GlaxoSmithKline plc's "Hold" Rating Reaffirmed at Kepler ...  Dakota Financial News
GlaxoSmithKline plc Rating Reiterated by Shore Capital (GSK)  WKRB News
GlaxoSmithKline plc Receives "Underperform" Rating from BNP Paribas (GSK)
GlaxoSmithKline plc logo GlaxoSmithKline plc (LON:GSK)'s stock had its �underperform� rating reiterated by analysts at BNP Paribas in a research report issued to clients and investors on Wednesday.
Shore Capital Reaffirms Buy Rating for GlaxoSmithKline plc (GSK)  The Legacy